REVEALED: Trial vaccine's alarming symptoms

 

A participant in one of the world's most promising COVID-19 vaccine trials reportedly had neurological symptoms, prompting the producer to pause the study.

Pharma giant AstraZeneca yesterday announced it would put its phase three clinical trials on hold after a study participant suffered a "potentially unexplained illness".

It has now emerged the woman experienced neurological symptoms consistent with a rare but serious spinal inflammatory disorder, Stat News reports. However, she is expected to be discharged from hospital soon.

A spokeswoman from AstraZeneca said yesterday: "As part of the ongoing randomised, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow review of safety data by an independent committee.

The deal will cost the government $1.7 billion but will mean Australia gets priority access to the Oxford University/AstraZeneca vaccine. Picture: Lisa Maree Williams/Getty Images
The deal will cost the government $1.7 billion but will mean Australia gets priority access to the Oxford University/AstraZeneca vaccine. Picture: Lisa Maree Williams/Getty Images

"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials while it is investigated, ensuring we maintain the integrity of the trials. In large trials illnesses will happen by chance, but must be independently reviewed to check this carefully."

British news outlet the Financial Times reported the clinical trial could resume next week, but AstraZeneca officials have not yet commented on the news


‘He lost a lot of blood’: Cop reveals harrowing ordeal

Premium Content ‘He lost a lot of blood’: Cop reveals harrowing ordeal

In the race to save a life, Jarrod French says every minute counts

‘Snippet of white man’s history’ set to be demolished

Premium Content ‘Snippet of white man’s history’ set to be demolished

Ballina councillors rejected a motion to keep Lennox Head pavilion

New Parkinson’s specialist nurse joins Tweed-Byron network

Premium Content New Parkinson’s specialist nurse joins Tweed-Byron network

People living with Parkinson’s disease now have added support